FDA Recognizes Orphan Drug Exclusivity for Adamas’ GOCOVRI™
25 oct. 2017 12h30 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Drug Products...